361
Views
27
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy

, , , , , & show all
Pages 611-616 | Received 08 Dec 2013, Accepted 01 Jan 2014, Published online: 11 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Umut Emre Aykut, Umit Akyuz, Atakan Yesil, Fatih Eren, Fatma Gerin, Rabia Ergelen, Cigdem Ataizi Celikel & Yusuf Yilmaz. (2014) A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 49:11, pages 1343-1348.
Read now

Articles from other publishers (26)

Beata Zyśk, Lucyna Ostrowska, Joanna Smarkusz-Zarzecka, Katarzyna Witczak-Sawczuk, Agnieszka Gornowicz & Anna Bielawska. (2023) Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study. International Journal of Molecular Sciences 24:3, pages 2891.
Crossref
Tugce OZLU, Yusuf YILMAZ & Fatma E. GUNES. (2022) The effects of dietary intervention on fibrosis and biochemical parameters in metabolic-associated fatty liver disease. Minerva Gastroenterology 68:4.
Crossref
Maryam Al-Hasani, Laith R. Sultan, Hersh Sagreiya, Theodore W. Cary, Mrigendra B. Karmacharya & Chandra M. Sehgal. (2022) Ultrasound Radiomics for the Detection of Early-Stage Liver Fibrosis. Diagnostics 12:11, pages 2737.
Crossref
Haluk Tarık KANİ, Çağlayan KEKLİKKIRAN, İlkay ERGENÇ & Yusuf YILMAZ. (2022) Evaluation of spleen stiffness in healthy population: a vibration-controlled transient elastography study. Journal of Health Sciences and Medicine 5:2, pages 689-692.
Crossref
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim & Beom Seok Kim. (2021) Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease. Diabetologia 65:3, pages 518-527.
Crossref
François Destrempes, Marc Gesnik, Boris Chayer, Marie-Hélène Roy-Cardinal, Damien Olivié, Jeanne-Marie Giard, Giada Sebastiani, Bich N. Nguyen, Guy Cloutier & An Tang. (2022) Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease. PLOS ONE 17:1, pages e0262291.
Crossref
Shuangzhen Jia, Yuzhen Zhao, Jiaqi Liu, Xu Guo, Moxian Chen, Shaoming Zhou & Jianli Zhou. (2022) Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy. Frontiers in Pediatrics 9.
Crossref
Eda Kaya & Yusuf Yilmaz. (2022) Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 13, pages 204201882211396.
Crossref
Jia-Feng Wu, Kai-Chi Chang, Yen-Hsuan Ni, Hong-Yuan Hsu & Mei-Hwei Chang. (2021) Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion. The Journal of Infectious Diseases 223:8, pages 1381-1389.
Crossref
Tao Wan & Annalisa Berzigotti. 2020. NAFLD and NASH. NAFLD and NASH 115 139 .
Kee-Huat Chuah & Wah-Kheong Chan. (2019) Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Current Hepatology Reports 18:4, pages 492-502.
Crossref
Haluk Tarik KANI, İlknur DELIKTAS & Yusuf YILMAZ. (2019) Prevalence of fatty liver disease in patients with inflammatory bowel disease: a transient elastography study on the basis of a controlled attenuation parameter. Marmara Medical Journal 32:2, pages 68-70.
Crossref
Minyoul Baik, Seung Up Kim, Hyo Suk Nam, Ji Hoe Heo & Young Dae Kim. (2019) The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke. Frontiers in Neurology 10.
Crossref
Na Di, Xinchuan Zhou, Yaxiao Chen, Xiaomiao Zhao, Lin Li, Linlin Jiang, Baoming Luo, Xiaoli Chen & Dongzi Yang. (2019) Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?. Archives of Endocrinology and Metabolism.
Crossref
Saeede Saadati, Behzad Hatami, Zahra Yari, Mohammad Amin Shahrbaf, Sareh Eghtesad, Asieh Mansour, Hossein Poustchi, Mehdi Hedayati, Morteza Aghajanpoor-pasha, Amir Sadeghi & Azita Hekmatdoost. (2019) The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. European Journal of Clinical Nutrition 73:3, pages 441-449.
Crossref
Razan M. Bader, Maureen M. Jonas, Paul D. Mitchell, Shanna Wiggins & Christine K. Lee. (2019) Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis. Journal of Cystic Fibrosis 18:2, pages 280-285.
Crossref
Pauline Verhaegh, Roisin Bavalia, Bjorn Winkens, Ad Masclee, Daisy Jonkers & Ger Koek. (2018) Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 16:6, pages 837-861.
Crossref
Jia-Feng Wu, Shih-Hsi Song, Chee-Seng Lee, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Tzee-Chung Wu & Mei-Hwei Chang. (2018) Clinical Predictors of Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection From Children to Adults. The Journal of Infectious Diseases 217:9, pages 1408-1416.
Crossref
Liang Xu, Wei Lu, Ping Li, Feng Shen, Yu-Qiang Mi & Jian-Gao Fan. (2017) A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B. Digestive and Liver Disease 49:8, pages 910-917.
Crossref
Wah‐Kheong Chan, Nik Raihan Nik Mustapha, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong & Sanjiv Mahadeva. (2017) Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non‐alcoholic fatty liver disease in an Asian population. United European Gastroenterology Journal 5:1, pages 76-85.
Crossref
Christiane Stern & Laurent Castera. (2016) Non-invasive diagnosis of hepatic steatosis. Hepatology International 11:1, pages 70-78.
Crossref
Eda Kaya, Dogac Demir, Yesim O. Alahdab & Yusuf Yilmaz. (2016) Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter. European Journal of Gastroenterology & Hepatology 28:11, pages 1264-1267.
Crossref
Nirav K. Desai, Sarah Harney, Roshan Raza, Alyaa Al-Ibraheemi, Nick Shillingford, Paul D. Mitchell & Maureen M. Jonas. (2016) Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. The Journal of Pediatrics 173, pages 160-164.e1.
Crossref
Ivana Mikolasevic, Lidija Orlic, Luka Zaputovic, Sanjin Racki, Zlatko Cubranic, Kata Anic, Bosiljka Devcic & Davor Stimac. (2015) Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease. Wiener klinische Wochenschrift 127:11-12, pages 451-458.
Crossref
Young Eun Chon, Kyu Sik Jung, Kwang Joon Kim, Dong Jin Joo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han & Seung Up Kim. (2014) Normal Controlled Attenuation Parameter Values: A Prospective Study of Healthy Subjects Undergoing Health Checkups and Liver Donors in Korea. Digestive Diseases and Sciences 60:1, pages 234-242.
Crossref
Yusuf Yilmaz & Fatih Eren. (2014) A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 26:11, pages 1292-1295.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.